<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
36000-059-06
</NDCCode>
<PackageDescription>
6 BAG in 1 CASE (36000-059-06) > 50 mL in 1 BAG
</PackageDescription>
<NDC11Code>
36000-0059-06
</NDC11Code>
<ProductNDC>
36000-059
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Ondansetron Hydrochloride And Dextrose
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Ondansetron Hydrochloride And Dextrose
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName>
INTRAVENOUS
</RouteName>
<StartMarketingDate>
20090414
</StartMarketingDate>
<EndMarketingDate>
20180228
</EndMarketingDate>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA078308
</ApplicationNumber>
<LabelerName>
Baxter Healthcare Corporation
</LabelerName>
<SubstanceName>
ONDANSETRON HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
32
</StrengthNumber>
<StrengthUnit>
mg/50mL
</StrengthUnit>
<Pharm_Classes>
Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2018-03-01
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20191231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20090414
</StartMarketingDatePackage>
<EndMarketingDatePackage>
20180228
</EndMarketingDatePackage>
<SamplePackage>
N
</SamplePackage>
</NDC>